The -137G>C polymorphism in interleukin-18 promoter region and cancer risk: evidence from a meta-analysis of 21 studies

Author： Liang Tie-Jun   Ma Hui   Wang Cong-Xiao   Liu Yin-Rong   Wang Xing-Guo  

Publisher： Springer Publishing Company

ISSN： 1010-4283

Source： Tumor Biology, Vol.34, Iss.6, 2013-12, pp. : 3483-3490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies

By Gao Lin-Bo  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 827-835

Springer Publishing Company

Access to resources Recommend Favorite

Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies

By Xu Lei   Zhou Xin   Xu Lin   Yin Rong  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1661-1669

Springer Publishing Company

Access to resources Recommend Favorite

PIN1 promoter polymorphism (842 G>C) contributes to a decreased risk of cancer: Evidence from metaanalysis

By                  

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1360-1366

Spandidos Publications

Access to resources Recommend Favorite

The -149C>T polymorphism of DNMT3B is not associated with colorectal cancer risk: Evidence from a meta-analysis based on case-control studies

By              

Experimental and Therapeutic Medicine, Vol. 4, Iss. 4, 2012-01 ,pp. : 728-732

Spandidos Publications

Access to resources Recommend Favorite

RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies

By Yu Ke-Da  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 365-371

Springer Publishing Company

Access to resources Recommend Favorite